Merck said it will file a lawsuit against the federal government seeking an injunction of the drug price negotiation program in the Inflation Reduction Act, arguing it violates the First and Fifth Amendments, Reuters reported June 6.
Read the full post on Becker's Hospital Review - Healthcare News
